| pubmed-article:9703232 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9703232 | lifeskim:mentions | umls-concept:C0040732 | lld:lifeskim |
| pubmed-article:9703232 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:9703232 | lifeskim:mentions | umls-concept:C0033567 | lld:lifeskim |
| pubmed-article:9703232 | lifeskim:mentions | umls-concept:C0152171 | lld:lifeskim |
| pubmed-article:9703232 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:9703232 | lifeskim:mentions | umls-concept:C0348016 | lld:lifeskim |
| pubmed-article:9703232 | lifeskim:mentions | umls-concept:C0449243 | lld:lifeskim |
| pubmed-article:9703232 | lifeskim:mentions | umls-concept:C0549178 | lld:lifeskim |
| pubmed-article:9703232 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:9703232 | pubmed:dateCreated | 1998-10-19 | lld:pubmed |
| pubmed-article:9703232 | pubmed:abstractText | Primary pulmonary hypertension (PPH) is a progressive disease with a median survival of less than 3 years from diagnosis. Medical management has typically consisted of anticoagulation and oral calcium channel blocking agents, whereas lung transplantation (LT) has been reserved for patients who are unresponsive to medical therapy. Continuous intravenous prostacyclin was introduced for patients who did not respond to calcium channel blockers and who would have required LT. We reviewed our experience with prostacyclin in LT candidates to study its effects on the timing and outcome of LT. | lld:pubmed |
| pubmed-article:9703232 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9703232 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9703232 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9703232 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9703232 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9703232 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9703232 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:9703232 | pubmed:issn | 1053-2498 | lld:pubmed |
| pubmed-article:9703232 | pubmed:author | pubmed-author:HarrisTT | lld:pubmed |
| pubmed-article:9703232 | pubmed:author | pubmed-author:RubinL JLJ | lld:pubmed |
| pubmed-article:9703232 | pubmed:author | pubmed-author:ConteJ VJV | lld:pubmed |
| pubmed-article:9703232 | pubmed:author | pubmed-author:GaineS PSP | lld:pubmed |
| pubmed-article:9703232 | pubmed:author | pubmed-author:OrensJ BJB | lld:pubmed |
| pubmed-article:9703232 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9703232 | pubmed:volume | 17 | lld:pubmed |
| pubmed-article:9703232 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9703232 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9703232 | pubmed:pagination | 679-85 | lld:pubmed |
| pubmed-article:9703232 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9703232 | pubmed:meshHeading | pubmed-meshheading:9703232-... | lld:pubmed |
| pubmed-article:9703232 | pubmed:meshHeading | pubmed-meshheading:9703232-... | lld:pubmed |
| pubmed-article:9703232 | pubmed:meshHeading | pubmed-meshheading:9703232-... | lld:pubmed |
| pubmed-article:9703232 | pubmed:meshHeading | pubmed-meshheading:9703232-... | lld:pubmed |
| pubmed-article:9703232 | pubmed:meshHeading | pubmed-meshheading:9703232-... | lld:pubmed |
| pubmed-article:9703232 | pubmed:meshHeading | pubmed-meshheading:9703232-... | lld:pubmed |
| pubmed-article:9703232 | pubmed:meshHeading | pubmed-meshheading:9703232-... | lld:pubmed |
| pubmed-article:9703232 | pubmed:meshHeading | pubmed-meshheading:9703232-... | lld:pubmed |
| pubmed-article:9703232 | pubmed:meshHeading | pubmed-meshheading:9703232-... | lld:pubmed |
| pubmed-article:9703232 | pubmed:meshHeading | pubmed-meshheading:9703232-... | lld:pubmed |
| pubmed-article:9703232 | pubmed:meshHeading | pubmed-meshheading:9703232-... | lld:pubmed |
| pubmed-article:9703232 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9703232 | pubmed:articleTitle | The influence of continuous intravenous prostacyclin therapy for primary pulmonary hypertension on the timing and outcome of transplantation. | lld:pubmed |
| pubmed-article:9703232 | pubmed:affiliation | Department of Surgery, The University of Maryland School of Medicine, Baltimore 21201, USA. | lld:pubmed |
| pubmed-article:9703232 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9703232 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9703232 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9703232 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9703232 | lld:pubmed |
